Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.63 | €70.00 | 56.845% |
Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.86 | €8.39 | 350.629% |
Edap Tms S.A. ADR | 3 | 1 | 1 | 0 | €6.75 | €14.79 | 119.141% |
Drägerwerk AG & Co. KGaA VZO | 3 | 0 | 1 | 0 | €50.70 | €57.50 | 13.412% |
Stratec SE | 2 | 0 | 0 | 0 | €42.70 | - | - |
Staar Surgical Co. | 11 | 1 | 4 | 0 | €44.22 | €49.02 | 10.850% |
Adverum Biotechnologies Inc. | 4 | 1 | 0 | 0 | €1.38 | €3.72 | 169.623% |
ProQR Therapeutics N.V. | 6 | 0 | 1 | 0 | €1.89 | €2.81 | 48.695% |
R1 RCM Inc. | 19 | 0 | 2 | 0 | €10.90 | €17.21 | 57.914% |
iRhythm Technologies Inc | 10 | 0 | 0 | 0 | €103.00 | €122.84 | 19.261% |
Pro-Dex Inc. | 16 | 0 | 0 | 0 | €16.90 | - | - |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €68.76 | €100.00 | 45.433% |
Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €36.60 | €46.08 | 25.908% |
Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
Catalyst Pharmaceutical Partners Inc | 10 | 0 | 0 | 0 | €14.20 | €23.46 | 65.239% |
Trinity Biotech ADR | 23 | 0 | 2 | 0 | €0.41 | - | - |
Verastem Inc. | 9 | 0 | 0 | 0 | €8.60 | €27.03 | 214.314% |
Xeris Biopharma Holdings Inc. | 4 | 0 | 0 | 0 | €1.64 | €4.39 | 168.253% |
US Physical Therapy Inc. | 7 | 1 | 0 | 0 | €93.00 | €108.77 | 16.955% |
Patterson Companies Inc. | 6 | 0 | 0 | 0 | €24.20 | €32.18 | 32.984% |
Cytokinetics Inc. | 24 | 1 | 3 | 0 | €58.50 | €85.64 | 46.399% |
Brookdale Sr Lvg | 2 | 0 | 1 | 0 | €6.35 | €8.27 | 30.280% |
Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.35 | - | - |
Clinica Baviera S.A. | 2 | 0 | 0 | 0 | €28.00 | - | - |
Owens & Minor Inc. | 2 | 1 | 0 | 0 | €22.40 | €24.04 | 7.331% |